Transcode Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.91

-1.06 (-10.63%)

As of Feb 8, 2:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +122.4% upside

Low Target $14.35

Average Target $19.82

High Target $27.60

Current Price $8.91

Current
$8.91

Target
$19.82

$14.35 $19.82 avg $27.60

Scenario Analysis

Bear Case

$14.35

61.1%

Low target

Base Case

$19.82

+122.4%

Avg target

Bull Case

$27.60

+209.8%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$22.25

-60.0% from high

52-Week Low

$13.08

+-31.9% from low

Target vs 52W High

$19.82

-10.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%